RESUMO
BACKGROUND: Relatively little is known about the dietary intake and nutritional status of community-based individuals with eating disorders. This research aimed to: (i) describe the dietary intake of population-based adolescents with an eating disorder and (ii) examine associations between eating disorder symptoms, fatty acid intake and depressive symptoms in adolescents with and without an eating disorder. METHODS: Data were drawn from the Western Australian Pregnancy Cohort (Raine) Study, a population-based cohort study that has followed participants from birth to young adulthood. This research utilised self-report data from the 17-year Raine Study assessment. Participants comprised 429 female adolescents who completed comprehensive questionnaire measures on dietary intake, eating disorder symptoms and depressive symptoms. RESULTS: Adolescents with an eating disorder (n = 66) reported a significantly lower intake of total fat, saturated fat, omega-6 fatty acid, starch, vitamin A and vitamin E compared to adolescents without an eating disorder (n = 363). Adolescents with an eating disorder and pronounced depressive symptoms (n = 23) also reported a significantly lower intake of polyunsaturated fat and omega-3 and omega-6 fatty acid than adolescents with an eating disorder but no marked depression (n = 43). In the eating disorder sample but not the control sample, omega-3 and omega-6 fatty acid correlated significantly and negatively with eating disorder symptoms and with depressive symptoms. CONCLUSIONS: Support is provided for a relationship between low omega-3 and omega-6 fatty acid intake and depressive symptoms in adolescents with eating disorders. Research is needed to examine the feasibility and effectiveness of fatty acid supplementation in this high-risk group.
Assuntos
Depressão/epidemiologia , Dieta , Ácidos Graxos Ômega-3/administração & dosagem , Ácidos Graxos Ômega-6/administração & dosagem , Transtornos da Alimentação e da Ingestão de Alimentos/epidemiologia , Adolescente , Austrália , Suplementos Nutricionais , Feminino , Seguimentos , Humanos , Modelos Lineares , Desnutrição/complicações , Desnutrição/dietoterapia , Estado Nutricional , Estudos Prospectivos , Inquéritos e QuestionáriosAssuntos
Ácido Fólico/uso terapêutico , Hiper-Homocisteinemia/prevenção & controle , Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos , Acidente Vascular Cerebral/prevenção & controle , Trombofilia/prevenção & controle , Vitamina B 12/uso terapêutico , Vitamina B 6/uso terapêutico , Austrália/epidemiologia , Estudos de Coortes , Método Duplo-Cego , Grão Comestível , Ácido Fólico/administração & dosagem , Alimentos Fortificados , Humanos , Hiper-Homocisteinemia/sangue , Hiper-Homocisteinemia/complicações , Ataque Isquêmico Transitório/etiologia , Ataque Isquêmico Transitório/prevenção & controle , Tamanho da Amostra , Prevenção Secundária , Acidente Vascular Cerebral/etiologia , Trombofilia/etiologia , Resultado do Tratamento , Vitamina B 12/administração & dosagem , Vitamina B 6/administração & dosagemAssuntos
Saúde Ambiental , Praguicidas , Ácido 2,4,5-Triclorofenoxiacético/intoxicação , Anormalidades Induzidas por Medicamentos/etiologia , Animais , Aves , DDT/intoxicação , Dioxinas/toxicidade , Contaminação de Medicamentos , Ecologia , Feminino , Humanos , Legislação de Medicamentos , Malária/prevenção & controle , Camundongos , Nova Zelândia , Controle Biológico de Vetores , Resíduos de Praguicidas , Praguicidas/normas , Gravidez , Ratos , Sri LankaRESUMO
OBJECTIVE: To examine trends in long term survival in patients alive 28 days after myocardial infarction and the impact of evidence based medical treatments and coronary revascularisation during or near the event. DESIGN: Population based cohort with 12 year follow-up. SETTING: Perth, Australia. PARTICIPANTS: 4451 consecutive patients with a definite acute myocardial infarction according to the World Health Organization MONICA (monitoring trends and determinants in cardiovascular disease) criteria admitted to hospital during 1984-7, 1988-90, and 1991-3. MAIN OUTCOME MEASURES: All cause mortality identified from official mortality records and the hospital morbidity data, with death from cardiovascular disease as a secondary end point. RESULTS: In the 1991-3 cohort, 28 day survivors of acute myocardial infarction had a 7.6% absolute event reduction (95% confidence interval 4% to 11%) or a 28% lower relative risk reduction (16% to 38%), unadjusted for risk of death, over 12 years after the incident admission compared with the 1984-7 cohort, similar to the survival of the 1988-90 cohort. The improved survival for the 1991-3 cohort persisted after adjustment for demographic factors, coronary risk factors, severity of disease, and event complications with an adjusted relative risk reduction of 26% (14% to 37%), but this was not apparent after further adjustment for medical treatments in hospital and coronary revascularisation procedures within 12 months of the incident myocardial infarction. CONCLUSION: The improving trends in 12 year survival after a definite acute myocardial infarction are associated with progressive use of evidence based treatments during the initial admission to hospital and in the 12 months after the event. These changes in the management of acute myocardial infarction are probably contributing to the continuing decline in mortality from coronary heart disease in Australia.